Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MYCOPHENOLATE MOFETIL ID: 744010, with a corresponding US DMF Number 32239.
Remarkably, this DMF maintains an Active status since its submission on February 17, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 05, 2021, and payment made on November 21, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II